Please login to the form below
BeneVir
This page shows the latest BeneVir news and features for those working in and with pharma, biotech and healthcare.
Transgene slumps as viral cancer therapy fails phase 3 trial
have tied up with Turnstone Biologics and BeneVir Biopharm, respectively.
Latest news
-
AZ invests more in IO with Transgene oncolytic virus deal
Companies such as AbbVie and J&J both struck deals in the field last year with biotech firms – Turnstone Biologics and BeneVir Biopharm respectively.
-
Vyriad inks immunotherapy alliance with Merck/Pfizer
companies. In May, Johnson &Johnson paid $140m upfront for BeneVir in a deal that could see its value head north of $1bn, while other deals have been done byand Pfizer, amongst
-
J&J moves quickly ahead with trials of myeloma CAR-T
Earlier this month it bought oncolytic virus player Benevir Biopharm for $140m upfront and up to $900m in milestones, and also has a collaboration with Aduro for cancer vaccine ADU-214
-
J&J pays $140m upfront for cancer-busting virus firm BeneVir
tumour immune response”, and the intention is clearly to test BeneVir’s candidates both alone and in combination with other drugs. ... After the acquisition goes through, BeneVir will maintain its R&D operations in Maryland, US, and become part of
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
Latest Intelligence
-
Cancer immunotherapy: What's on the horizon?
Meanwhile, AbbVie and Johnson &Johnson have both struck deals this year with biotechs in this field – Turnstone Biologics and BeneVir Biopharm respectively – suggesting the oncolytic virus sector is heating up.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Sanofi's frexalimab shows promise in relapsing forms of MS
- Seqera Labs and Genomics England partner to progress genomic research
- AbbVie’s Rinvoq receives FDA approval for Crohn’s disease
- Amgen reports positive results for Otezla in psoriatic arthritis
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Supporting the most vulnerable: why pharma should get behind the NHS’ healthcare equity campaign
- Healing the Healers
- The (inevitable) digital transformation of Medical Affairs
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Pfizer’s RSV vaccine approved by FDA for older adults
No results were found
PMHub
Life Healthcare Communications
Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...
Latest intelligence
- Healing the Healers
- Because if we do not heal the healers, who is going to heal us?...
- The (inevitable) digital transformation of Medical Affairs
- It’s not a question of ‘if,’ it’s a question of ‘when.’...
- Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment
- Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts...
